Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. enVVeno Medical's annualizedGross Profit for the quarter that ended in Mar. 2024 was $0.00 Mil.
enVVeno Medical's average Total Assets over the quarter that ended in Mar. 2024 was $46.73 Mil. Therefore, enVVeno Medical's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 0.00%.
enVVeno Medical Gross-Profit-to-Asset % Historical Data
The historical data trend for enVVeno Medical's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of enVVeno Medical's Gross-Profit-to-Asset %
For the Medical Devices subindustry, enVVeno Medical's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
enVVeno Medical's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, enVVeno Medical's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where enVVeno Medical's Gross-Profit-to-Asset % falls into.
enVVeno Medical Gross-Profit-to-Asset % Calculation
enVVeno Medical's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Mar. 2024) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
enVVeno Medical Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of enVVeno Medical's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
enVVeno Medical (enVVeno Medical) Business Description
enVVeno Medical Corp is a medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its lead product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NVNO has been successfully added to your 